L.A. Kondili, M.G. Quaranta, L. Ferrigno, C. Coppola, M. Monti, R. Filomia, G. Brancaccio, M.R. Brunetto, E. Biliotti, D. Ieluzzi, A. Iannone, S. Madonia, X. Tata, L. Cavalletto, V. Cossiga, S. Amodeo, V. Calvaruso, E. Rosselli del Turco, M.G. Rumi, M. Pompili, A. Ciancio, L. Brescini, F.P. Russo.
De-novo occurrence of portal vein thrombosis in patients with HCV-related cirrhosis after sustained virological response: medium to long term observations from the ongoing PITER cohort
The International Liver Congress 2022. 57nd annual meeting of the European Association for the Study of the Liver (EASL). Londra 22-26 Giugno 2022
L.A. Kondili, M.G. Quaranta, L. Ferrigno, C. Coppola, M. Monti, R. Filomia, G. Brancaccio, M.R. Brunetto, E. Biliotti, D. Ieluzzi, A. Iannone, S. Madonia, X. Tata, L. Cavalletto, V. Cossiga, S. Amodeo, V. Calvaruso, E. Rosselli del Turco, M.G. Rumi, M. Pompili, A. Ciancio, L. Brescini, F.P. Russo.
De-novo occurrence of portal vein thrombosis in patients with HCV-related cirrhosis after sustained virological response: medium to long term observations from the ongoing PITER cohort
Riunione Annuale AISF 2022. Roma, 24-25 Marzo 2022
B. Coco, M.E. Tosti, G. Raimondo, C. Coppola, L. Chessa, T. Santantonio, G.B. Gaeta, G. Brancaccio, A. Marzano, M. Milella, V. Messina, F.P. Russo, A.M. Cattelan, P. Lampertico, E. Claar, P.L. Blanc, F. Morisco, G. Verucchi, D. Ieluzzi, S. Madonia, L. Chemello, M.G. Rumi, C. Torti, G. Morsica, A. Federico, A. Giorgini, A.L. Zignego, M. Anselmo, A. Colecchia, P. Toniutto, F. Piscaglia, A. Ciancio, M. Puoti, N. Coppola, G.F. Foschi, G. Nardone, G. D'Offizi, F. Castelli, C. Mazzaro, A. Mastroianni, A. Licata, I. Maida, G. Di Perri, V. Di Marco, M.G. Quaranta, L.A. Kondili.
Epidemiological, virological and clinical profile of HBsAg positive individuals in Italian hospital settings: interim results of the HBV/HDV PITER cohort
Riunione Annuale AISF 2022. Roma, 24-25 Marzo 2022
LA Kondili, MG Quaranta, L Cavalletto, L Ferrigno, C Coppola, DC Amoruso, G Brancaccio, G. Raimondo, R Filomia, MR. Brunetto, B Coco, AL Zignego, M Monti, A Iannone, S Madonia, D Ieluzzi, G Taliani, E Biliotti, G Verucchi, L Badia, G Migliorino, I Beretta, M Massari, A Licata, A R Capitano, F Barbaro, M Zuin, A Giorgini, M Persico, M Masarone, F P Russo, A Zanetto, F Morisco, V Cossiga, P Blanc, P Pierotti, A Craxì, V Calvaruso, L Chemello on behalf of PITER Collaborating Group.
De novo hepatocellular carcinoma occurrence following the HCV viral eradsication by direct acting antivirals (DAA): medium to long term observations from the ongoing PITER cohort
The Liver Meeting, AASLD 2021 12-15 Novembre 2021
MG Quaranta, L Ferrigno, M Monti, R Filomia, E Biliotti, A Iannone, G Migliorino, B Coco, F Morisco, M Vinci, R D'Ambrosio, L Chemello, M Massari, D Ieluzzi, FP Russo, P Blanc, G Verucchi, M Puoti, MG Rumi, F Barbaro, TA Santantonio, A Federico, L Chessa, I Gentile, M Zuin, G Parruti, G Morsica, LA Kondili on behalf of PITER Collaborating Group.
Advanced liver disease outcomes after Hepatitis C viral eradication according to Human Immunodeficiency Virus coinfection in PITER cohort
12° Congresso Nazionale ICAR "Italian Conference on AIDS and Antiviral Research, Digital Edition 12-16 ottobre 2020
X Tata, A Marcellusi, G Fabiano, S Ryder, M Buti, L Gheorghe, C Coppola, A Craxì, FS Mennini, LA Kondili.
Clinical and economic consequences of antiviral treatment for Hepatitis C chronic infection in Europe: analysis of England, Italy, Romania and Spain data
The Digital International Liver Congress™ 2020. 55th Annual meeting of the European Association for the Study of the Liver (EASL). 27-29 Agosto 2020
R Rossotti, A Tavelli, MG Quaranta, L Ferrigno, F Bai, F Barbaro, A Cingolani, M Dallio, M Loi, E Zappullo, A d’Arminio Monforte, M Puoti.
HIV/HCV co-infected subjects show better thrombocytopenia improvement after SVR achievement than HCV mono-infected cirrhotics. Data from the HepaICONA and PITER cohorts
The Digital International Liver Congress™ 2020. 55th Annual meeting of the European Association for the Study of the Liver (EASL). 27-29 Agosto 2020
LA Kondili, MG Quaranta, M Monti, DC Amoruso, R Filomia, E Biliotti, A Iannone, D Ieluzzi, B Coco, FP Russo, I Beretta, G Parruti, P Blanc, M Vinci, V Cossiga, E Degasperi, L Chemello, M Massari, L Badia, M Puoti, SR Bruno, M De Siena, V Panetta, A Aghemo.
The weight of pre-existing cofactors for liver disease progression in patients who successfully eradicated HCV virus infection: An interim analysis in the PITER cohort
The Digital International Liver Congress™ 2020. 55th Annual meeting of the European Association for the Study of the Liver (EASL). 27-29 Agosto 2020
LA Kondili, MG Quaranta, M Monti, DC Amoruso, R Filomia, E Biliotti, A Iannone, D Ieluzzi, B Coco, FP Russo, I Beretta, G Parruti, P Blanc, M Vinci, V Cossiga, E Degasperi, L Chemello, M Massari, L Badia, M Puoti, SR Bruno, M De Siena, V Panetta, A Aghemo.
The weight of pre-existing cofactors for liver disease progression in patients who successfully eradicated HCV virus infection: An interim analysis in the PITER cohort
53nd Annual Meeting of the Italian Association for the Study of the Liver (AISF). Roma, 27-28 Febbraio 2020
LA Kondili, M Monti, G Ferrante, MG Quaranta, F Madia, M Vinci, G Borgia, G Brancaccio, B Coco, M Margotti, L Chemello, A Ciancio, MG Rumi, M Puoti, S Madonia, AL Fracanzani, M Persico, R Filomia, E Biliotti, A Benedetti, E Negri, D Ieluzzi, C Coppola, TA Santantonio, AL Zignego and PITER Collaborating Group.
Long term effectiveness of DAA therapy in patients with chronic HCV and Mixed Cryoglobulinemic Syndrome
XVIII Congresso Nazionale SIMIT, Palermo, 24-27 Novembre 2019
MG Quaranta, L Ferrigno, F D'Angelo, C Viscoli, G Morsica, P Blanc, M Puoti, M Massari, G Verucchi, L Chessa, L Kondili and PITER Collaborating Group.
Outcomes of advanced liver disease in patients with chronic hepatitis C with and without HIV coinfection following sustained virological response: a real life evaluation in the PITER cohort
XVIII Congresso Nazionale SIMIT, Palermo, 24-27 Novembre 2019
LA Kondili, I Gamkrelidze, S Blach, A Marcellusi, M Galli, S Petta, M Puoti, S Vella, A Craxì, H Razavi, FS Mennini on behalf of PITER collaborating group.
Optimization of Hepatitis C Virus screening strategies by birth cohort in Italy
XVIII Congresso Nazionale SIMIT, Palermo, 24-27 Novembre 2019
LA Kondili, M Monti, G Ferrante, MG Quaranta, F Madia, M Vinci, G Borgia, G Brancaccio, B Coco, M Margotti, L Chemello, A Ciancio, MG Rumi, M Puoti, S Madonia, AL Fracanzani, M Persico, R Filomia, E Biliotti, A Benedetti, E Negri, D Ieluzzi, C Coppola, TA Santantonio, AL Zignego and PITER Collaborating Group.
Long term effectiveness of DAA therapy in patients with chronic HCV and Mixed Cryoglobulinemic Syndrome
The Liver Meeting, AASLD 2019. Boston, 8-12 Novembre 2019
MG Quaranta, L Ferrigno, F D'Angelo, C Viscoli, G Morsica, P Blanc, M Puoti, M Massari, G Verucchi, L Chessa, L Kondili and PITER Collaborating Group.
Outcomes of advanced liver disease in patients with chronic hepatitis C with and without HIV coinfection following sustained virological response: a real life evaluation in the PITER cohort
The Liver Meeting, AASLD 2019. Boston, 8-12 Novembre 2019
G Ferrante, LA Kondili, M Monti, MG Quaranta, F Madia, M Vinci, G Borgia, G Brancaccio, B Coco, AL Zignego.
Efficacia a lungo termine dei farmaci ad azione diretta nei pazienti con epatite C cronica e sindrome crioglobulinemica
53° Convegno Associazione Italiana di Epidemiologia (AIE). Catania, 24 Ottobre 2019
LA Kondili, MG Quaranta, A Marcellusi, A Craxì, M Puoti, I Gamkrelidze, S Blach, H Razavi, FS Mennini, and PITER Collaborating Group.
Screening strategies for hepatitis C virus elimination in Italy
ICAR 2019. XI Italian conference on AIDS and Antiviral Research, Milano, 5-7 Giugno 2019
C Estes, L Kondili, MG Quaranta, A Craxì, S Petta, M Masarone, FP Russo, M Siciliano, B Coco, R Filomia, H Razavi.
Modeling NAFLD-Related Disease Progression among the PITER SVR12 Cohort
The International Liver Congress™ 2019. 54th Annual meeting of the European Association for the Study of the Liver (EASL). Vienna 10-14 Aprile 2019
MG Quaranta, S Rosato, L Ferrigno, DC Amoruso, M Monti, P Di Stefano, R Filomia, F Tamburini, G Migliorino, A Zanetto, E Degasperi, L Cavalletto, G Brancaccio, P Blanc, M Cannizzaro, E Castelli, G Morsica, A Licata, LA Kondili.
Real life data on elbasvir/grazoprevir efficacy, safety and drug-drug interaction profile in patients with chronic hepatitis C viral infection: a prospective analysis in the PITER cohort
The International Liver Congress™ 2019. 54th Annual meeting of the European Association for the Study of the Liver (EASL). Vienna 10-14 Aprile 2019
MG Quaranta, S Rosato, L Ferrigno, DC Amoruso, M Monti, P Di Stefano, R Filomia, F Tamburini, G Migliorino, A Zanetto, E Degasperi, L Cavalletto, G Brancaccio, P Blanc, M Cannizzaro, E Castelli, G Morsica, A Licata, LA Kondili on behalf of PITER collaborating group.
Real life data on elbasvir/grazoprevir efficacy, safety and drug-drug interaction profile in patients with chronic hepatitis C viral infection: a prospective analysis in the PITER cohort
52nd Annual Meeting of the Italian Association for the Study of the Liver. Roma 21-22 Febbraio 2019
MG Quaranta, A Marcellusi, R Viti, L Ferrigno, DC Amoruso, M Monti, B Coco, R Filomia, S Bruno, A Iannone, E Biliotti, A Giorgini, M Loi, V Calvaruso, AR Buonomo, V Guarneri, A Zanetto, F Baragli, V Cossiga, MC Gizzi, E Castelli, M Cannizzaro, D Ieluzzi, M Vinci, M Masarone, L Cavalletto, R Corsini, A Licata F Mennini, L Kondili, e Gruppo collaborativo PITER.
Analisi modellistica sulle conseguenze cliniche ed economiche del trattamento antivirale contro l’infezione cronica da HCV nella coorte reale PITER
XVII Congresso Nazionale SIMIT, Torino, 2-5 Dicembre 2018
LA Kondili, MG Quaranta, S Rosato, LE Weimer, F D'Angelo, C Coppola, AL Zignego, MR Brunetto, G Raimondo, TA Santantonio, A Iannone, G Taliani, M Zuin, L Chessa, A Craxì, G Borgia, P Andreone, FP Russo, P Blanc, F Morisco, G Parruti, F Barbaro, S Madonia, F Capra, M Vinci, M Persico, L Chemello, A Gori, M Massari, M Puoti, A Licata, E Villa e Gruppo Collaborativo PITER.
Fattori predittivi della progressione della malattia del fegato in pazienti con risposta sierologica sostenuta indotta dai DAA: dati della coorte reale PITER
XVII Congresso Nazionale SIMIT, Torino, 2-5 Dicembre 2018
LA Kondili, MG Quaranta, S Rosato, LE Weimer, F D'Angelo, C Coppola, AL Zignego, MR Brunetto, G Raimondo, TA Santantonio, A Iannone, G Taliani, M Zuin, L Chessa, A Craxì, G Borgia, P Andreone, FP Russo, P Blanc, F Morisco, G Parruti, F Barbaro, S Madonia, F Capra, M Vinci, M Persico, L Chemello, A Gori, M Massari, M Puoti, A Licata, E Villa and PITER collaborating Group.
Predictive Factors for Liver Disease Progression Following the Direct Acting Antivirals Induced Sustained Virological Response: Data from the Italian Platform for the Study of Viral Hepatitis Therapies (PITER) Cohort
The Liver Meeting, AASLD 2018. San Francisco, 9-13 Novembre 2018 (POSTER of DISTINCTION)
LA Kondili, A Marcellusi, R Viti, MG Quaranta, L Ferrigno, DC Amoruso, M Monti, B Coco, R Filomia, S Bruno, A Iannone, E Biliotti, A Giorgini, M Loi, V Calvaruso, AR Buonomo, V Guarneri, A Zanetto, F Baragli, V Cossiga, MC Gizzi, E Castelli, M Cannizzaro, D Ieluzzi, M Vinci, M Masarone, L Cavalletto, R Corsini, A Licata, F Mennini and PITER collaborating Group.
Epidemiological and economic evaluations according to DAA treatment access in Italy based on real life PITER cohort data
The Liver Meeting, AASLD 2018. San Francisco, 9-13 Novembre 2018
R Viti, A Marcellusi, L Kondili, S Rosato, S Vella, FS Mennini.
Economic consequences of anti-HCV antiviral treatment investment from the NHS perspective
12th European Conference on Health Economics (EuHEA), MECC Maastricht, the Netherlands,11-14 Luglio 2018
LA Kondili, S Robbins, S Blach, I Gamkrelidze, AL Zignego, MR Brunetto, G Raimondo, G Taliani, A Iannone, FP Russo, T Santantonio, M Zuin, L Chessa, PL Blanc, M Puoti, M Vinci, EM Erne, M Strazzabosco, M Massari, P Lampertico, MG Rumi, A Federico, C Ferrari, A Ciancio, G Borgia, P Andreone, N Caporaso, M Persico, D Ieluzzi, A Gori, A Gasbarrini, C Coppola, G. Brancaccio, A Andriulli, S Montilla, H Razavi, M Melazzini, S Vella, A Craxì on behalf of PITER collaborating group.
Forecasting Hepatitis C liver disease burden based on real life data. Does the hidden iceberg matter to reach the World Health Organization elimination goals?
ICAR 2018. X Italian conference on AIDS and Antiviral Research, Roma, 22-24 Maggio 2018
A Saracino, D Bavaro, S Rosato, A Giorgini, R Corsini, E Castelli, M Vinci, F Baragli, E Biliotti, A Orlandini, M Monti, A Zanetto, C Baiguera, G Morsica, A Soria, S Bruno, A Ciancio, V Donati, V Calvaruso, MG Quaranta on behalf of PITER collaborating group.
Access to anti-HCV treatment with DAAs in the migrant population in Italy: data from the PITER cohort
ICAR 2018. X Italian conference on AIDS and Antiviral Research, Roma, 22-24 Maggio 2018
S Vella, L Kondili, A Marcellusi, R Viti, S Rosato, MG Quaranta, ME Tosti, L Ferrigno, F Mennini.
Epidemiological and economic evaluations according to DAA treatment access: an interim evaluation based on PITER cohort data
International Symposium on HIV and Emerging Infectious Diseases (ISHEID 2018), Marsiglia, 16-18 Maggio 2018.
S Robbins, LA Kondili, S Blach, I Gamkrelidze, AL Zignego, MR Brunetto, G Raimondo, G Taliani, A Iannone, FP Russo, T Santantonio, M Zuin, L Chessa, PL Blanc, M Puoti, M Vinci, EM Erne, M Strazzabosco, M Massari, P Lampertico, MG Rumi, A Federico, C Ferrari, A Ciancio, G Borgia, P Andreone, N Caporaso, M Persico, D Ieluzzi, A Gori, A Gasbarrini, C Coppola, GB Gaeta, A Andriulli, S Montilla, H Razavi, M Melazzini, S Vella, A Craxì on behalf of PITER collaborating group.
Forecasting liver disease burden based on a real life cohort of the linked to care patients in Italy. Does the "underwater portion of the iceberg" matter to reach the WHO HCV eliminating goals in the high HCV prevalent countries?
The International Liver Congress™ 2018. 53rd Annual meeting of the European Association for the Study of the Liver (EASL). Parigi 11-15 Aprile 2018
LA Kondili, MG Quaranta, S Rosato, M Monti, B Coco, R Filomia, E Biliotti, A Iannone, A Zanetto, S Bruno, A Giorgini, M Loi, F Baragli, C Baiguera, M Vinci, E Castelli, A Ciaccio, R Corsini, R D'Ambrosio, S Labanca, M Dallio, A Orlandini, A Ciancio, AR Buonomo, V Guarneri, V Cossiga, M Masarone, D Ieluzzi, M Cannizzaro, A Soria, M Siciliano, DC Amoruso, G Brancaccio, LE Weimer, L Ferrigno, ME Tosti, C Estes, H Razavi, V Calvaruso, on behalf of PITER collaborating group.
Multifactor risk evaluation in patients who have eradicated HCV infection: an interim analysis in the PITER cohort
The International Liver Congress™ 2018. 53rd Annual meeting of the European Association for the Study of the Liver (EASL). Parigi 11-15 Aprile 2018
S Robbins, LA Kondili, S Blach, I Gamkrelidze, AL Zignego, MR Brunetto, G Raimondo, G Taliani, A Iannone, FP Russo, T Santantonio, M Zuin, L Chessa, PL Blanc, M Puoti, M Vinci, EM Erne, M Strazzabosco, M Massari, P Lampertico, MG Rumi, A Federico, C Ferrari, A Ciancio, G Borgia, P Andreone, N Caporaso, M Persico, D Ieluzzi, A Gori, A Gasbarrini, C Coppola, S Madonia, GB Gaeta, A Andriulli, S Montilla, H Razavi, M Melazzini, S Vella, A Craxì on behalf of PITER collaborating group.
Forecasting liver disease burden based on a real life cohort of the linked to care patients in Italy. Does the "underwater portion of the iceberg" matter to reach the WHO HCV eliminating goals in the high HCV prevalent countries?
51st Annual Meeting of the Italian Association for the Study of the Liver. Roma 22, 23 Febbraio 2018
LA Kondili, MR Brunetto, G Taliani, AL Zignego, GB Gaeta, M Strazzabosco, G Raimondo, D Ieluzzi, A Iannone, P Andreone, TA Santantonio, A Craxì, FP Russo, M Puoti, G Borgia, M Zuin, M Siciliano, L Chessa, A Gori, M Massari, M Persico, F Morisco, P Blanc, A Federico, EM Erne, A Alberti, C Torti, MG Rumi, M Vinci, A Orlandini, G Montalto, A Giacometti, CM Mastroianni, I Serio, P Toniutto, A Aghemo, G Morsica, R Gulminetti, G Verucchi, J Vecchiet, F Castelli, V Zuccaro, A Benedetti, S Fargion, M Anselmo, M Galli, LE Weimer, S Rosato, MG Quaranta, S Vella.
Real life clinical outcomes in DAA-treated and untreated patients with HCV advanced liver disease. Interim one year data from the ongoing PITER cohort
The Liver Meeting, AASLD 2017. Washington, DC 20-24 Ottobre, 2017
LA Kondili, MR Brunetto, G Taliani, AL Zignego, GB Gaeta, M Strazzabosco, G Raimondo, D Ieluzzi, A Iannone, P Andreone, TA Santantonio, A Craxì, FP Russo, M Puoti, G Borgia, M Zuin, M Siciliano, L Chessa, A Gori, M Massari, M Persico, F Morisco, P Blanc, A Federico, EM Erne, A Alberti, C Torti, MG Rumi, M Vinci, A Orlandini, G Montalto, A Giacometti, CM Mastroianni, I Serio, P Toniutto, A Aghemo, G Morsica, R Gulminetti, G Verucchi, J Vecchiet, F Castelli, V Zuccaro, A Benedetti, S Fargion, M Anselmo, M Galli, LE Weimer, S Rosato, MG Quaranta, S Vella.
Real life clinical outcomes in DAA-treated and untreated patients with HCV advanced liver disease. Interim one year data from the ongoing PITER cohort
XVI Congresso Nazionale SIMIT, Salerno, 15-18 Ottobre, 2017
LA Kondili, GB Gaeta, MR Brunetto, D Ieluzzi, G Raimondo, R Filomia, AL Zignego, M Monti, B Coco, MG Rumi, A Di Leo, A Iannone, TA Santantonio, A Giammario, C Coppola, DC Amoruso, P Blanc, B Del Pin, L Chemello, L Cavalletto, F Morisco, L Donnarumma, A Gasbarrini, M Siciliano, M Massari, R Corsini, S Madonia, FP Russo, A Zanetto, M Persico, M Masarone, E Villa, V Bernabucci, G Taliani, E Biliotti, L Chessa, MC Pasetto, P Andreone, M Margotti, G Brancaccio, G Borgia, E Zappulo, V Calvaruso, S Petta, S Rosato, MG Quaranta, L Falzano, S Vella, EG Giannini.
DAA failure and clinical impact of retreatment in a real-life setting of patients with HCV-related advanced liver disease. Evaluation from the PITER network
XVI Congresso Nazionale SIMIT, Salerno, 15-18 Ottobre, 2017
M Ruggeri, F Romano, S Coretti, L Kondili, S Vella, FR Rolli, C Drago, A Cicchetti and PITER Collaborating Group.
Cost Effectiveness analysis of different health policies based on the second generation DAA-IFN free regimens in an Italian population
12th World Congress of the International Health Economics Association. Boston 7-11 Giugno, 2017
M Ruggeri, F Romano, S Coretti, L Kondili, S Vella, FR Rolli, C Drago, A Cicchetti and PITER Collaborating Group.
Cost Effectiveness analysis of different health policies based on the second generation DAA-IFN free regimens in an Italian population
2017 iHEA World Congress - Revolutions in the Economics of Health Systems. Roma 17-21 Giugno, 2017
LA Kondili, M Monti, V Rizzo, E Zappulo, L Chemello, M Vinci, M Margotti, M Puoti, M Persico, S Madonia, B Coco, D Ieluzzi, MG Rumi, R Corsini, G Lazzarini, E Biliotti, C Cerva, M Gonzo, A Federico, AL Zignego.
Diagnostic and IFN-Free therapeutic spproach of HCV+ Mixed Cryoglobulinemia in PITER (Piattaforma Italiana per lo Studio della Terapia delle Epatiti Virali) Cohort
The 4th International Congress on Controversies in Rheumatology & Autoimmunity, CORA 2017, Bologna 9-11 Marzo 2017
LA Kondili, M Monti, GB Gaeta, V Rizzo, G Borgia, E Zappulo, L Chemello, L Cavalletto, M Vinci, S Palladini, P Andreone, M Margotti, M Puoti, E Danieli, M Persico, M Masarone, S Madonia, , MR Brunetto, B Coco, D Ieluzzi, N Passigato, MG Rumi, V Sciola, M Massari, R Corsini, G Mazzella, G Lazzarini, G Taliani, E Biliotti, M Andreoni, C Cerva, A Alberti, M Gonzo, L Chessa, MC Pasetto, A Federico, M Dallio, MG Quaranta, LE Weimer, S Vella, AL Zignego.
Diagnostic and therapeutic approaches of Mixed Cryoglobulinemia in PITER (Piattaforma Italiana per lo studio della Terapia delle Epatiti viRali) cohort
The International Liver Congress™ 2017. 52nd annual meeting of the European Association for the Study of the Liver (EASL). Amsterdam 19-23 Aprile 2017
L Kondili, A Di Leo, A Iannone, T Santantonio, A Giammario, G Raimondo, R Filomia, C Coppola, D Amoruso, P Blanc, B Del Pin, L Chemello, L Cavalletto, F Morisco, L Donnarumma, MG Rumi, A Gasbarrini, M Siciliano, M Massari, R Corsini, MR Brunetto, B Coco, S Madonia, AL Zignego, M Monti, FP Russo, A Zanetto, M Persico, M Masarone, E Villa, V Bernabucci, G Taliani, E Biliotti, L Chessa, MC Pasetto19, P Andreone, M Margotti, GB Gaeta, V Rizzo, D Ieluzzi, G Borgia, E Zappulo, V Calvaruso, S Petta, FR Rolli, L Falzano, S Rosato, M Ruggeri.
Clinical characterization and economic impact evaluation of anti- HCV DAA treatment failure: real life data from the Italian Platform for the Study of Viral Hepatitis Therapies (PITER)
The International Liver Congress™ 2017. 52nd annual meeting of the European Association for the Study of the Liver (EASL). Amsterdam 19-23 Aprile 2017
LA Kondili, F Romano, M Ruggeri, S Rosato, MR Brunetto, AL Zignego, A Ciancio, A Di Leo, G Raimondo, C Ferrari, G Taliani, G Borgia, TA Santantonio, P Blanc, GB Gaeta, A Gasbarrini, L Chessa, EM Erne, E Villa, D Ieluzzi, FP Russo, P Andreone, M Vinci, C Coppola, L Chemello, S Madonia, G Verucchi, M Persico, M Zuin, M Puoti, A Alberti, G Nardone, V De Maria, M Massari, G Montalto, G Foti, MG Rumi, A Cicchetti, A Craxì, S Vella.
Health gains and costs of HCV treatment: a cost effectiveness analysis of two different health policies scenarios simulated in PITER (Piattaforma Italiana per lo studio della Terapia delle Epatiti viRali) real life cohort
The Liver Meeting, AASLD 2016. Boston 11-15 Novembre 2016. (POSTER of DISTINCTION)
S Rosato, LA Kondili, MG Quaranta, LE Weimer, L Falzano, A Mallano, ME Tosti, M Massella, S Vella e il gruppo di coordinamento del Progetto PITER.
Priorità del trattamento secondo l'algoritmo EASL HCV CPG 015: una valutazione real-life sulla coorte PITER (Piattaforma Italiana per lo studio della Terapia delle Epatiti viRali)
40° Congresso AIE 2016 - Le evidenze in epidemiologia: una storia lunga 40 anni, Torino 19-21 Ottobre 2016
LA Kondili, F Romano, M Ruggeri, S Rosato, MR Brunetto, AL Zignego, A Ciancio, A Di Leo, G Raimondo, C Ferrari, G Taliani, G Borgia, TA Santantonio, P Blanc, GB Gaeta, A Gasbarrini, L Chessa, EM Erne, E Villa, D Ieluzzi, FP Russo, P Andreone, M Vinci, C Coppola, L Chemello, S Madonia, G Verucchi, M Persico, M Zuin, M Puoti, A Alberti, G Nardone, V De Maria, M Massari, G Montalto, G Foti, MG Rumi, A Cicchetti, A Craxì, S Vella and PITER Collaborating Group.
Health gains and costs of HCV treatment: a cost-effectiveness analysis of two different health policies scenarios simulated in PITER (Piattaforma italiana per lo studio della terapia delle epatiti virali) real life cohort
XV Congresso Nazionale SIMIT, Baveno 16-19 Ottobre 2016
LA Kondili, L. Falzano, A Di Leo, A Iannone, T Santantonio, A Giammario, G Raimondo, R Filomia, C Coppola, D Amoruso, P Blanc, B Del Pin, L Chemello, L Cavalletto, F Morisco, L Donnarumma, MG Rumi, A Gasbarrini, M Siciliano10, M Massari, R Corsini, MR Brunetto, B Coco, S Madonia, AL Zignego, M Monti, FP Russo, E Franceschet, M Persico, M Masarone, E Villa, V Bernabucci, G Taliani, E Biliotti, L Chessa, MC Pasetto, P Andreone, M Margotti, GB Gaeta, V Rizzo, D Ieluzzi, V Calvaruso, S Petta, FR Rolli, F Romano, M Ruggeri and PITER Collaborating Group.
Clinical characterization and economic impact evaluation of anti-HCV DAA treatment failure: real life data from the Italian platform for the study of viral hepatitis therapies (PITER)
XV Congresso Nazionale SIMIT, Baveno 16-19 Ottobre 2016
MG Quaranta, G Brancaccio, S Fargion, L Valenti, A Giacometti, D Drenaggi, A Benedetti, MG Faraci, C Torti, A Strazzulla, G Angarano, M Milella, C Mastroianni, T Thieghi, P Toniutto, M Colombo, M Borghi, A Gori, E Cappelletti, F Castelli, S Zaltron, A Lazzarin, S Salpietro, F Rosina, L Framarin, C Viscoli, LA Nicolini, N Coppola, C Monari, R Gulminetti, A Gatti Comini, D Bartolozzi, E Salomoni, L Bolondi, F Baldelli, F Di Candilo, GB Gaeta and PITER Collaborating Group.
Difference in age distribution of the three major HCV genotypes in Italy and impact on comorbidities. analysis of the PITER cohort
XV Congresso Nazionale SIMIT, Baveno 16-19 Ottobre 2016
LA Kondili, L Falzano, A Di Leo, A Iannone, T Santantonio, A Giammario, G Raimondo, R Filomia, C Coppola, D Amoruso, P Blanc, B Del Pin, L Chemello, L Cavalletto, F Morisco, L Donnarumma, MG Rumi, A Gasbarrini, M Siciliano, M Massari, R Corsini, MR Brunetto, B Coco, S Madonia, AL Zignego, M Monti, FP Russo, E Franceschet, M Persico, M Masarone, E Villa, V Bernabucci, G Taliani, E Biliotti, L Chessa, MC Pasetto, P Andreone, M Margotti, GB Gaeta, V Rizzo, D Ieluzzi, V Calvaruso, S Petta and PITER Collaborating Group.
Clinical characterization and economic impact evaluation of anti-HCV DAA treatment failure: real life data from the Italian Platform for the Study of Viral Hepatitis Therapies (PITER)
EASL Special Conference. Parigi 23-24 Settembre 2016
B Coco on behalf of PITER and ICONA/HepaICONA Studies.
Clinical and virological characteristics of HIV and HCV coinfected versus HCV monoinfected patients: real life evaluation in PITER and ICONA/HepaICONA Italian cohorts
ICAR 2016. VIII Italian conference on AIDS and Antiviral Research, Milano, 6-8 Giugno 2016
L Kondili, MG Quaranta, L Falzano, M Di Gregorio, M Brunetto, AL Zignego, A Ciancio, A Di Leo, M Rendina, G Raimondo, C Ferrari, A Craxì, G Taliani, G Borgia, I Gentile, TA Santantonio, A Giammario, P Blanc, GB Gaeta, A Gasbarrini, M Siciliano, L Chessa, EM Erne, D Ieluzzi, FP Russo, P Andreone, M Vinci, C Coppola, L Chemello, S Madonia, G Verucchi, M Persico, M Zuin, A Alberti, M Puoti, G Nardone, V De Maria, M Massari, G Montalto, G Foti, MG Rumi, A Giacometti, A Benedetti, G D'Offizi, M Strazzabosco, S Fargion, G Angarano, A Federico, N Caporaso, C Mastroianni, P Toniutto, M Colombo, A Lazzarin, C Torti, M Andreoni, F Rosina, C Viscoli, S Vella, E Villa and PITER collaborating Group.
Gender differences in HCV chronic liver disease: a real life evaluation in PITER (Piattaforma Italiana Per Lo Studio Della Terapia Delle Epatiti Virali) Cohort Study. The International Liver Congress™ 2016
51st annual meeting of the European Association for the Study of the Liver (EASL). Barcellona, 13-17 Aprile 2016
L Kondili, LE Weimer, A Mallano, L Fucili, M Massella, M Vinci, G Borgia, M Brunetto, L Sturace, GB Gaeta, L Chemello, P Andreone, G Raimondo, R Filomia, M Persico, M Puoti, MG Rumi, A Benedetti, S Fargion, D Ieluzzi, G Nardone, G Foti, A Ciancio, G Taliani, E Biliotti,S Madonia, B Stagno, A Alberti, M Massari, F Rosina, G Mazzella, A Di Leo, A Iannone, C Ferrari, A Orlandini, M Monti, TA Santantonio, L Chessa, EM Erne, C Coppola, M Andreoni, F Baldelli, M Mondelli,P Blanc, A Gasbarrini, G Verucchi, M Colombo, M Borghi, A Craxì, S Petta, E Villa, O Patti, FP Russo, M Strazzabosco, S Vella, AL Zignego.
HCV-related mixed cryoglobulinemia: data from PITER, a nationwide Italian HCV cohort study. The International Liver Congress™ 2016
51st annual meeting of the European Association for the Study of the Liver (EASL). Barcellona, 13-17 Aprile 2016
LE Weimer, M Vinci, G Borgia, M Brunetto, L Sturace, GB Gaeta, L Chemello, A Buggio, P Andreone, G Raimondo, R Filomia, M Persico, M Puoti, MG Rumi, A Benedetti, S Fargion, D Ieluzzi, G Nardone, G Foti, A Ciancio, G Taliani, E Biliotti, S Madonia, B Stagno, A Alberti, M Massari, F Rosina, G Mazzella, A Di Leo, A Iannone, C Ferrari, A Orlandini, L Gragnani, TA Santantonio, L Chessa, EM Erne, C Coppola, M Andreoni, F Baldelli, M Mondelli, P Blanc, A Gasbarrini, F D'Aversa, G Verucchi, M Colombo, M Borghi, A Craxì, S Petta, E Villa, O Patti, FP Russo, M Strazzabosco, A Mallano, L Fucili, M Massella1, L Kondili, S Vella, AL Zignego and ISS&AISF &SIMIT collaborating Group in PITER.
HCV-related mixed cryoglobulinemia: data from PITER, a nationwide Italian HCV cohort study
49th Annual Meeting of the Italian Association for the Study of the Liver. Roma 18-19 Febbraio 2016
M Brunetto, AL Zignego, A Ciancio, A Di Leo, M Rendina, G Raimondo, C Ferrari, A Craxì, G Taliani, G Borgia, I Gentile, TA Santantonio, P Blanc, GB Gaeta, A Gasbarrini, M Siciliano, L Chessa, EM Erne, D Ieluzzi, FP Russo, P Andreone, M Vinci, C Coppola, L Chemello, S Madonia, G Verucchi, M Persico, M Zuin, A Alberti, M Puoti, G Nardone, V De Maria, M Massari, G Montalto, G Foti, MG Rumi, A Giacometti, A Benedetti, G D'Offizi, M Strazzabosco, S Fargion, G Angarano, A Federico, N Caporaso, C Mastroianni, P Toniutto, M Colombo, A Lazzarin, C Torti, M Andreoni, F Rosina, C Viscoli,L Falzano, L Kondili, MG Quaranta, M Di Gregorio, S Vella, E Villa and ISS&AISF&SIMIT collaborating Group in PITER.
Gender differences in HCV chronic liver disease: A real life evaluation in PITER (Piattaforma Italiana per lo studio della Terapia delle Epatiti viRali) cohort study
49th Annual Meeting of the Italian Association for the Study of the Liver. Roma 18-19 Febbraio 2016
P Colombatto, E Biliotti, D Palazzo, A Ciancio, B Del Pin, V Rizzo, G Brancaccio, MC Pasetto, E Castelli, D Ieluzzi, E Franceschet, S Storato, M Margotti, E Castelli, S Palladini, DC Amoruso, A Buggio, S Madonia, C Cerva, D Bartolozzi, F Castelli, R Gulminetti, G Mazzella, L Bolondi, F Baldelli, M Angelico, R Bruno, A Gori, G D'Adamo, G Leandro, J Vecchiet, A Picardi, V Vullo, M Libanore, N Coppola, A Grieco, L Raffaele, M Mondelli, R Cauda, M Galli, G Di Perri, A Floreani, A D'Arminio Monforte, MG Quaranta, L Kondili, S Rosato, M Mirra, ME Tosti, S Vella and ISS&AISF&SIMIT Collaborating Group in PITER.
Clinical and virological characteristics of HIV and HCV co-infected versus HCV monoinfected patients: a real-life evaluation in the PITER (Piattaforma Italiana per lo studio della Terapia delle Epatiti viRali) cohort
49th Annual Meeting of the Italian Association for the Study of the Liver. Roma 18-19 Febbraio 2016
LA Kondili, S Rosato, MG Quaranta, LE Weimer, L Falzano, A Mallano, ME Tosti, M Massella, MR Brunetto, AL Zignego, M Rizzetto, A Di Leo, G Raimondo, C Ferrari, G Taliani, P Blanc, A Gasbarrini, L Chessa, EM Erne, G Fattovich, P Andreone, M Vinci, FP Russo, E Villa, GB Gaeta, T A Santantonio, G Borgia, G Verucchi, C Coppola, M Persico, L Chemello, A Alberti, V De Maria, M Puoti, R Bruno, P Caraceni, M Andreoni, M Marzioni, S Vella, A Craxì on the behalf of PITER Collaborating Group.
Treatment priotization according to the EASL HCV CPG: a real life evaluation on the PITER
The Liver Meeting – AASLD 2015, San Francisco, 13-17 Novembre 2015
LA Kondili, S Rosato, LE Weimer, MG Quaranta, L Falzano, A Mallano, ME Tosti, M Massella, MR Brunetto, AL Zignego, M Rizzetto, A Di Leo, G Raimondo, C Ferrari, A Craxì, G Taliani, P Blanc, A Gasbarrini, L Chessa, EM Erne, G Fattovich, P Andreone, M Vinci, FP Russo, E Villa, GB Gaeta, TA Santantonio, G Borgia, G Verucchi, C Coppola, M Persico, L Chemello, A Alberti, V De Maria, M Puoti, R Bruno, P Caraceni, M Andreoni, M Marzioni, S Vella on the behalf of PITER Collaborating Group.
Male gender, genotype 3, previous alcohol use, increased BMI, and diabetes are factors independently correlated to advanced HCV chronic liver disease in Italy: data from PITER (Piattaforma Italiana per lo studio della Terapia delle Epatiti viRali) cohort study
The Liver Meeting – AASLD 2015, San Francisco, 13-17 Novembre 2015
A Orlandini, C Ferrari, G Taliani, E Biliotti, G Montalto, AR Capitano, A Giacometti, P Castelli, S Fargion, L Valenti, G Angarano, M Milella, S Madonia, B Stagno, M Andreoni, N Cesta, D Bartolozzi, E Salomoni, C Torti, V Pisani, A Gori, S Costarelli, J Vecchiet, K Falasca, M Libanore, D Segala, S Rosato, L Falzano, MG Quaranta and PITER Collaborating Group.
Factors that influence HCV related liver disease severity in Italian patients in care: data from PITER (Piattaforma Italiana per lo studio della Terapia delle Epatiti ViRali) HCV cohort study"
XIV Congresso SIMIT, Catania, 8-11 Novembre 2015
P Blanc, B Del Pin Barbara, EM Elke, D Piovan, G Borgia, I Gentile, G Verucchi, L Badia, M Puoti, E Danieli, D Ieluzzi, S Storato, TA Santantonio, M Ciarallo, C Mastroianni, T Tieghi , G Foti, S Pellicano, A Lazzarin, S Salpietro, C Viscoli, A Di Biagio, F Castelli, S Odolini Silvia, F Baldelli, F Di Candilo, R Gulminetti, A Gatti Comini, A Mallano, M Massella, LE Weimer and PITER Collaborating Group.
Clinical and virological characteristics of HIV and HCV co-infected versus HCV mono-infected patients: a real-life evaluation in the PITER cohort
XIV Congresso Nazionale SIMIT, Catania, 8-11 Novembre 2015
LE Weimer, L Falzano, A Mallano, MG Quaranta, M Massella, S Rosato, P Colombatto, L Giubilei, A Ciancio, A Iannone, R Filomia, A Orlandini, S Petta, F Tamburrini, P Blanc, F D'Aversa, MC Pasetto, ME Erne, D Ieluzzi, S Storato, M Margotti, M Vinci, G Gottardo, O Patti, V Rizzo, A Giammario, I Gentile, V Donati, L Staiano, M Masarone, D Sterrantino, M Gonzo, F Giancotti, E Danieli, R Corsini, MG Faraci, L Valenti, M Cappelletti, S Camera, S Pellicano, B Stagno, T Tieghi, M Milella, M Dallio, A Rocco, M Borghi, D Drenaggi, S Zaltron, S Salpietro, L Framarin, AR Capitano, C Cerva, A Di Biagio, LA Kondili and PITER Collaborating Group.
NAFLD: a cofactor or bystander on HCV disease progression? Baseline results from patients enrolled in the PITER cohort study
Monotematica AISF: "NASH malattia epatica, oncologica e cardiovascolare". Modena 8-10 Ottobre 2015